Physician profile
Demarcus D Smith
NPI 1306940556
$19,888.36
in general payments reported to CMS, 2019-2025
7 companies · $1,095 in 2025
The $1,095 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,800 · 2020: $3,583 · 2021: $6,829 · 2022: $2,840 · 2023: $986 · 2024: $755 · 2025: $1,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $177.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $17,703.70 | 2019-2025 | |
| Nobel Biocare USA | $902.61 | 2019-2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $713.30 | 2019-2021 | |
| Zimvie INC. | $316.92 | 2022-2025 | |
| Biohorizons Implant Systems INC. | $142.74 | 2020-2024 | Biohorizons |
| Geistlich Pharma, North America, INC. | $66.49 | 2019-2024 | Geistlich Bio-Gide |
| Pacira Pharmaceuticals Incorporated | $42.60 | 2020-2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demarcus Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.